Anhua Wu

648 citations
23 papers · 466 indexed · h-index 11
Topics
Nanoplatforms for cancer theranostics (3 papers)Meningioma and schwannoma management (3 papers)Glioma Diagnosis and Treatment (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Anhua Wu

22 papers receiving 463 citations

Peers

Anhua Wu
Comparison fields: 5 of 88
  • Molecular Biology 154
  • Pulmonary and Respiratory Medicine 122
  • Genetics 96
  • Cancer Research 82
  • Oncology 73
Replace Jinglin Wang with:
Jinglin Wang China
Jae Young Choi South Korea
Tae Yeon Kim South Korea
Neal Shah United States
Jieying Wu China
Rongfu Liu China
Xiaojun He China
Susan K. Brusnahan United States
Anhua Wu relative to Jinglin Wang China Jinglin Wang's profile →
Citations per field
00.5×4.1×
Jinglin Wang · 1×
Citations per year

Countries citing papers authored by Anhua Wu

Since Specialization
Citations

This map shows the geographic impact of Anhua Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anhua Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anhua Wu more than expected).

Fields of papers citing papers by Anhua Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anhua Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anhua Wu. The network helps show where Anhua Wu may publish in the future.

Co-authorship network of co-authors of Anhua Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Anhua Wu. A scholar is included among the top collaborators of Anhua Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anhua Wu. Anhua Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 11
3 11
4 6
5 1
6 1
7 26
8 13
9 155
10 4
11 44
12 5
13 34
14
Increase of plasma IgE during treatment correlates with better outcome of patients with glioblastoma.
8
15 62
16 26
17 6
18 6
19 12
20
Rhabdomyolysis and Staphylococcus aureus septicemia in a man with the acquired immunodeficiency syndrome.
10

About Anhua Wu

Anhua Wu is a scholar working on Leadership and Management, Immunology and Allergy and Genetics, having authored 23 papers that have together received 466 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Meningioma and schwannoma management (3 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Genetics (96 citations), Cancer Research (82 citations) and Nephrology (29 citations). Anhua Wu has collaborated with scholars based in China and United States. Frequent co-authors include Sheng Han, Wen Cheng, Chuanbao Zhang, Jinquan Cai, Yang Liu, Xiufang Ren, Bo Qiu, Yang Zhang, Chao Wang and Shouqiang Cao. Their work appears in journals such as PLoS ONE, Neurology and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026